Report Detail

Pharma & Healthcare Global Ropivacaine Hydrochloride Injection Market Insights, Forecast to 2025

  • RnM3819457
  • |
  • 07 November, 2019
  • |
  • Global
  • |
  • 119 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Table of Contents

    1 Study Coverage

    • 1.1 Ropivacaine Hydrochloride Injection Product Introduction
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Ropivacaine Hydrochloride Injection Market Size Growth Rate by Type
      • 1.4.2 2 Mg/ml
      • 1.4.3 5 Mg/ml
      • 1.4.4 7.5 Mg/ml
      • 1.4.5 10 Mg/ml
    • 1.5 Market by Application
      • 1.5.1 Global Ropivacaine Hydrochloride Injection Market Size Growth Rate by Application
      • 1.5.2 Surgical Anesthesia
      • 1.5.3 Acute Pain Management
      • 1.5.4 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Ropivacaine Hydrochloride Injection Market Size
      • 2.1.1 Global Ropivacaine Hydrochloride Injection Revenue 2014-2025
      • 2.1.2 Global Ropivacaine Hydrochloride Injection Sales 2014-2025
    • 2.2 Ropivacaine Hydrochloride Injection Growth Rate by Regions
      • 2.2.1 Global Ropivacaine Hydrochloride Injection Sales by Regions
      • 2.2.2 Global Ropivacaine Hydrochloride Injection Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Ropivacaine Hydrochloride Injection Sales by Manufacturers
      • 3.1.1 Ropivacaine Hydrochloride Injection Sales by Manufacturers
      • 3.1.2 Ropivacaine Hydrochloride Injection Sales Market Share by Manufacturers
    • 3.2 Ropivacaine Hydrochloride Injection Revenue by Manufacturers
      • 3.2.1 Ropivacaine Hydrochloride Injection Revenue by Manufacturers (2014-2019)
      • 3.2.2 Ropivacaine Hydrochloride Injection Revenue Share by Manufacturers (2014-2019)
    • 3.3 Ropivacaine Hydrochloride Injection Price by Manufacturers
    • 3.4 Ropivacaine Hydrochloride Injection Manufacturing Base Distribution, Product Types
      • 3.4.1 Ropivacaine Hydrochloride Injection Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Ropivacaine Hydrochloride Injection Product Type
      • 3.4.3 Date of International Manufacturers Enter into Ropivacaine Hydrochloride Injection Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type

    • 4.1 Global Ropivacaine Hydrochloride Injection Sales by Type
    • 4.2 Global Ropivacaine Hydrochloride Injection Revenue by Type
    • 4.3 Ropivacaine Hydrochloride Injection Price by Type

    5 Breakdown Data by Application

    • 5.1 Overview
    • 5.2 Global Ropivacaine Hydrochloride Injection Breakdown Data by Application

    6 North America

    • 6.1 North America Ropivacaine Hydrochloride Injection by Country
      • 6.1.1 North America Ropivacaine Hydrochloride Injection Sales by Country
      • 6.1.2 North America Ropivacaine Hydrochloride Injection Revenue by Country
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Ropivacaine Hydrochloride Injection by Type
    • 6.3 North America Ropivacaine Hydrochloride Injection by Application

    7 Europe

    • 7.1 Europe Ropivacaine Hydrochloride Injection by Country
      • 7.1.1 Europe Ropivacaine Hydrochloride Injection Sales by Country
      • 7.1.2 Europe Ropivacaine Hydrochloride Injection Revenue by Country
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Ropivacaine Hydrochloride Injection by Type
    • 7.3 Europe Ropivacaine Hydrochloride Injection by Application

    8 Asia Pacific

    • 8.1 Asia Pacific Ropivacaine Hydrochloride Injection by Region
      • 8.1.1 Asia Pacific Ropivacaine Hydrochloride Injection Sales by Region
      • 8.1.2 Asia Pacific Ropivacaine Hydrochloride Injection Revenue by Region
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 South Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Thailand
      • 8.1.10 Malaysia
      • 8.1.11 Philippines
      • 8.1.12 Vietnam
    • 8.2 Asia Pacific Ropivacaine Hydrochloride Injection by Type
    • 8.3 Asia Pacific Ropivacaine Hydrochloride Injection by Application

    9 Central & South America

    • 9.1 Central & South America Ropivacaine Hydrochloride Injection by Country
      • 9.1.1 Central & South America Ropivacaine Hydrochloride Injection Sales by Country
      • 9.1.2 Central & South America Ropivacaine Hydrochloride Injection Revenue by Country
      • 9.1.3 Brazil
    • 9.2 Central & South America Ropivacaine Hydrochloride Injection by Type
    • 9.3 Central & South America Ropivacaine Hydrochloride Injection by Application

    10 Middle East and Africa

    • 10.1 Middle East and Africa Ropivacaine Hydrochloride Injection by Country
      • 10.1.1 Middle East and Africa Ropivacaine Hydrochloride Injection Sales by Country
      • 10.1.2 Middle East and Africa Ropivacaine Hydrochloride Injection Revenue by Country
      • 10.1.3 Turkey
      • 10.1.4 GCC Countries
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Ropivacaine Hydrochloride Injection by Type
    • 10.3 Middle East and Africa Ropivacaine Hydrochloride Injection by Application

    11 Company Profiles

    • 11.1 Pfizer
      • 11.1.1 Pfizer Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Pfizer Ropivacaine Hydrochloride Injection Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Pfizer Ropivacaine Hydrochloride Injection Products Offered
      • 11.1.5 Pfizer Recent Development
    • 11.2 Fresenius Kabi
      • 11.2.1 Fresenius Kabi Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Fresenius Kabi Ropivacaine Hydrochloride Injection Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Fresenius Kabi Ropivacaine Hydrochloride Injection Products Offered
      • 11.2.5 Fresenius Kabi Recent Development
    • 11.3 Akorn
      • 11.3.1 Akorn Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Akorn Ropivacaine Hydrochloride Injection Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Akorn Ropivacaine Hydrochloride Injection Products Offered
      • 11.3.5 Akorn Recent Development
    • 11.4 Nephron Pharmaceuticals
      • 11.4.1 Nephron Pharmaceuticals Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Nephron Pharmaceuticals Ropivacaine Hydrochloride Injection Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Nephron Pharmaceuticals Ropivacaine Hydrochloride Injection Products Offered
      • 11.4.5 Nephron Pharmaceuticals Recent Development
    • 11.5 Sintetica
      • 11.5.1 Sintetica Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Sintetica Ropivacaine Hydrochloride Injection Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Sintetica Ropivacaine Hydrochloride Injection Products Offered
      • 11.5.5 Sintetica Recent Development
    • 11.6 Chengdu Tiantaishan Pharmaceutical
      • 11.6.1 Chengdu Tiantaishan Pharmaceutical Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Chengdu Tiantaishan Pharmaceutical Ropivacaine Hydrochloride Injection Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Chengdu Tiantaishan Pharmaceutical Ropivacaine Hydrochloride Injection Products Offered
      • 11.6.5 Chengdu Tiantaishan Pharmaceutical Recent Development
    • 11.7 Haisco Pharmaceutical Group
      • 11.7.1 Haisco Pharmaceutical Group Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Haisco Pharmaceutical Group Ropivacaine Hydrochloride Injection Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Haisco Pharmaceutical Group Ropivacaine Hydrochloride Injection Products Offered
      • 11.7.5 Haisco Pharmaceutical Group Recent Development
    • 11.8 Zhuhai Yipin Pharmaceutical Group
      • 11.8.1 Zhuhai Yipin Pharmaceutical Group Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Zhuhai Yipin Pharmaceutical Group Ropivacaine Hydrochloride Injection Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Zhuhai Yipin Pharmaceutical Group Ropivacaine Hydrochloride Injection Products Offered
      • 11.8.5 Zhuhai Yipin Pharmaceutical Group Recent Development
    • 11.9 Qilu Pharmaceutical
      • 11.9.1 Qilu Pharmaceutical Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Qilu Pharmaceutical Ropivacaine Hydrochloride Injection Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Qilu Pharmaceutical Ropivacaine Hydrochloride Injection Products Offered
      • 11.9.5 Qilu Pharmaceutical Recent Development

    12 Future Forecast

    • 12.1 Ropivacaine Hydrochloride Injection Market Forecast by Regions
      • 12.1.1 Global Ropivacaine Hydrochloride Injection Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Ropivacaine Hydrochloride Injection Revenue Forecast by Regions 2019-2025
    • 12.2 Ropivacaine Hydrochloride Injection Market Forecast by Type
      • 12.2.1 Global Ropivacaine Hydrochloride Injection Sales Forecast by Type 2019-2025
      • 12.2.2 Global Ropivacaine Hydrochloride Injection Revenue Forecast by Type 2019-2025
    • 12.3 Ropivacaine Hydrochloride Injection Market Forecast by Application
    • 12.4 North America Ropivacaine Hydrochloride Injection Forecast
    • 12.5 Europe Ropivacaine Hydrochloride Injection Forecast
    • 12.6 Asia Pacific Ropivacaine Hydrochloride Injection Forecast
    • 12.7 Central & South America Ropivacaine Hydrochloride Injection Forecast
    • 12.8 Middle East and Africa Ropivacaine Hydrochloride Injection Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Ropivacaine Hydrochloride Injection Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      This report studies the global market size of Ropivacaine Hydrochloride Injection in key regions like North America, Europe, China and Japan, focuses on the consumption of Ropivacaine Hydrochloride Injection in these regions.
      This research report categorizes the global Ropivacaine Hydrochloride Injection market by top players/brands, region, type and end user. This report also studies the global Ropivacaine Hydrochloride Injection market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Pfizer
      Fresenius Kabi
      Akorn
      Nephron Pharmaceuticals
      Sintetica
      Chengdu Tiantaishan Pharmaceutical
      Haisco Pharmaceutical Group
      Zhuhai Yipin Pharmaceutical Group
      Qilu Pharmaceutical

      Ropivacaine Hydrochloride Injection market size by Type
      2 Mg/ml
      5 Mg/ml
      7.5 Mg/ml
      10 Mg/ml

      Ropivacaine Hydrochloride Injection market size by Applications
      Surgical Anesthesia
      Acute Pain Management
      Other

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Asia-Pacific
      China
      Japan
      South Korea
      India
      Australia
      Indonesia
      Thailand
      Malaysia
      Philippines
      Vietnam
      Central & South America
      Brazil
      Middle East & Africa
      Turkey
      GCC Countries
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Ropivacaine Hydrochloride Injection market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Ropivacaine Hydrochloride Injection market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Ropivacaine Hydrochloride Injection companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Ropivacaine Hydrochloride Injection submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Ropivacaine Hydrochloride Injection are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Ropivacaine Hydrochloride Injection market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


      Summary:
      Get latest Market Research Reports on Ropivacaine Hydrochloride Injection. Industry analysis & Market Report on Ropivacaine Hydrochloride Injection is a syndicated market report, published as Global Ropivacaine Hydrochloride Injection Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Ropivacaine Hydrochloride Injection market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,027.15
      4,540.73
      6,054.31
      3,535.89
      5,303.83
      7,071.78
      423,852.00
      635,778.00
      847,704.00
      279,983.73
      419,975.60
      559,967.46
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report